- Investing Ideas
- /
- Retail Healthcare Sector
Retail Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Entera Bio
Market Cap: US$92.3m
A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.
ENTX
US$2.03
7D
-5.6%
1Y
-16.8%
Ironwood Pharmaceuticals
Market Cap: US$92.2m
A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.
IRWD
US$0.57
7D
-19.6%
1Y
-91.2%
Trajan Group Holdings
Market Cap: AU$144.0m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.94
7D
12.5%
1Y
-5.5%
Cibus
Market Cap: US$92.1m
An agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products.
CBUS
US$2.82
7D
31.5%
1Y
-84.8%
Immunic
Market Cap: US$92.1m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.96
7D
-4.9%
1Y
-22.8%
Cardiol Therapeutics
Market Cap: CA$128.5m
A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.56
7D
-2.8%
1Y
-46.9%
Monogram Technologies
Market Cap: US$91.4m
Engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States.
MGRM
US$2.59
7D
-3.0%
1Y
25.1%
Contineum Therapeutics
Market Cap: US$90.8m
A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.
CTNM
US$3.51
7D
-9.3%
1Y
-77.4%
Zentalis Pharmaceuticals
Market Cap: US$90.7m
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.
ZNTL
US$1.26
7D
2.4%
1Y
-89.6%
Corbus Pharmaceuticals Holdings
Market Cap: US$89.8m
A biopharmaceutical company, develops products to defeat serious illness.
CRBP
US$7.34
7D
13.8%
1Y
-83.7%
CareCloud
Market Cap: US$88.9m
A healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.10
7D
10.2%
1Y
-25.5%
Odysight.ai
Market Cap: US$88.5m
Develops, produces, and markets visualization AI solutions in Israel, the United States, and internationally.
ODYS
US$5.43
7D
-2.1%
1Y
-23.5%
Coherus BioSciences
Market Cap: US$88.2m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$0.76
7D
-21.4%
1Y
-64.1%
Oramed Pharmaceuticals
Market Cap: US$87.8m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$2.15
7D
-4.4%
1Y
-6.5%
Grown Rogue International
Market Cap: CA$122.7m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.54
7D
-5.3%
1Y
-51.4%
Genetic Signatures
Market Cap: AU$136.3m
Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
GSS
AU$0.60
7D
-7.7%
1Y
-20.0%
Caribou Biosciences
Market Cap: US$87.3m
A clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally.
CRBU
US$0.94
7D
21.2%
1Y
-72.3%
Climb Bio
Market Cap: US$87.2m
A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.
CLYM
US$1.29
7D
8.4%
1Y
-84.4%
Owlet
Market Cap: US$87.1m
Provides digital parenting solutions in the United States, the United Kingdom, and internationally.
OWLT
US$5.27
7D
8.9%
1Y
33.4%
Champions Oncology
Market Cap: US$87.0m
A technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States.
CSBR
US$6.35
7D
2.1%
1Y
35.1%
Sera Prognostics
Market Cap: US$87.0m
A women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States.
SERA
US$2.31
7D
4.1%
1Y
-72.0%
Applied Therapeutics
Market Cap: US$85.4m
A clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States.
APLT
US$0.60
7D
50.8%
1Y
-85.6%
Anixa Biosciences
Market Cap: US$85.3m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$2.65
7D
1.5%
1Y
-7.0%
Cyclopharm
Market Cap: AU$132.8m
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.
CYC
AU$1.20
7D
-11.5%
1Y
-25.3%
Elicio Therapeutics
Market Cap: US$85.0m
A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.
ELTX
US$5.33
7D
-2.9%
1Y
-47.0%
Auxly Cannabis Group
Market Cap: CA$118.6m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.09
7D
0%
1Y
80.0%
Pliant Therapeutics
Market Cap: US$84.7m
A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.
PLRX
US$1.38
7D
-2.1%
1Y
-91.0%
Adagene
Market Cap: US$83.4m
A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.
ADAG
US$1.77
7D
10.6%
1Y
-30.6%
NetraMark Holdings
Market Cap: CA$116.1m
Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.
AIAI
CA$1.44
7D
12.5%
1Y
388.1%
Senti Biosciences
Market Cap: US$82.9m
A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
SNTI
US$3.18
7D
-2.5%
1Y
-16.8%
Fractyl Health
Market Cap: US$82.8m
A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.
GUTS
US$1.69
7D
4.3%
1Y
-76.1%
Paradigm Biopharmaceuticals
Market Cap: AU$128.5m
Engages in the research and development of therapeutic products for human use in Australia.
PAR
AU$0.33
7D
4.8%
1Y
22.2%
Prenetics Global
Market Cap: US$82.1m
A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.
PRE
US$6.30
7D
16.9%
1Y
8.5%
FONAR
Market Cap: US$81.7m
Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.
FONR
US$12.90
7D
4.1%
1Y
-15.4%
Planet 13 Holdings
Market Cap: CA$113.8m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.35
7D
0%
1Y
-57.3%
Galectin Therapeutics
Market Cap: US$81.0m
A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.
GALT
US$1.28
7D
-7.2%
1Y
-60.4%